Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Dec-17 4:52 PM View:  | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 15,731 | -- | -- | (100%) 15.73K to 0 | |
| 03-Nov-16 9:54 PM View: | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 1,657 | $28.35 | $46,975.90 | (100%) 1.66K to 0 | |
| 03-Aug-16 6:20 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 03-Aug-16 | Market Sale | 129 | $8.15 | $1,051.35 | (4%) 3.17K to 3.04K | (411%) |
| 03-Aug-16 6:20 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 02-Aug-16 | Market Sale | 32 | $8.71 | $278.72 | (< 1%) 3.2K to 3.17K | (378%) |
| 03-Aug-16 6:20 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 01-Aug-16 | Market Sale | 84 | $8.82 | $740.88 | (3%) 3.28K to 3.2K | (372%) |
| 02-May-16 4:42 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 28-Apr-16 | Market Sale | 235 | $6.96 | $1,635.60 | (7%) 3.52K to 3.28K | (499%) |
| 08-Mar-16 11:52 AM View: | Syndax Pharmaceuticals Inc (SNDX) | 08-Mar-16 | Conversion | 13,925 | -- | -- | 100% 0 to 13.93K | |
| 11-May-15 4:07 PM View: | Colucid Pharmaceuticals, Inc. (CLCD) | 11-May-15 | Conversion | 3,519 | -- | -- | 100% 0 to 3.52K | |
| 07-Aug-14 3:23 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 05-Aug-14 | Conversion | 17,000 | -- | -- | 100% 0 to 17.0K | |
| 05-May-14 11:51 AM View: | Aldeyra Therapeutics, Inc. (ALDX) | 01-May-14 | Conversion | 9,208 | -- | -- | 100% 0 to 9.21K | |
| 21-Mar-14 7:02 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 78,369 | $14.00 | $1,097,170.00 | (100%) 78.37K to 0 | < 1% |
| 17-Jan-14 4:16 PM View: | Alimera Sciences Inc (ALIM) | 16-Jan-14 | Market Sale (Planned) | 2,230 | $6.56 | $14,628.80 | (6%) 37.14K to 34.91K | 95% |
| 17-Jan-14 4:16 PM View: | Alimera Sciences Inc (ALIM) | 15-Jan-14 | Market Sale (Planned) | 1,010 | $6.01 | $6,070.10 | (3%) 38.15K to 37.14K | 95% |
| 28-Aug-13 11:49 AM View: | Tobira Therapeutics, Inc. (TBRA) | 27-Aug-13 | Conversion | 14,539 | -- | -- | 3816% 0.38K to 14.92K | |
| 24-Jun-13 4:28 PM View: | Alimera Sciences Inc (ALIM) | 20-Jun-13 | Market Sale (Planned) | 114 | $5.01 | $571.14 | (< 1%) 38.26K to 38.15K | 94% |
| 20-Jun-13 5:19 PM View: | Alimera Sciences Inc (ALIM) | 19-Jun-13 | Market Sale (Planned) | 244 | $5.37 | $1,310.28 | (< 1%) 38.51K to 38.26K | 94% |
| 20-Jun-13 5:19 PM View: | Alimera Sciences Inc (ALIM) | 18-Jun-13 | Market Sale (Planned) | 359 | $5.40 | $1,938.60 | (< 1%) 38.86K to 38.51K | 95% |
| 18-Jun-13 5:07 PM View: | Alimera Sciences Inc (ALIM) | 17-Jun-13 | Market Sale (Planned) | 959 | $5.40 | $5,178.60 | (2%) 39.82K to 38.86K | 95% |
| 18-Jun-13 5:07 PM View: | Alimera Sciences Inc (ALIM) | 14-Jun-13 | Market Sale (Planned) | 425 | $5.03 | $2,137.75 | (1%) 40.25K to 39.82K | 94% |
| 13-Jun-13 5:07 PM View: | Alimera Sciences Inc (ALIM) | 11-Jun-13 | Market Sale (Planned) | 59 | $5.00 | $295.00 | (< 1%) 40.31K to 40.25K | 94% |
| 17-May-13 5:36 PM View: | Alimera Sciences Inc (ALIM) | 16-May-13 | Market Sale | 232 | $4.50 | $1,044.00 | (< 1%) 40.54K to 40.31K | 93% |
| 17-May-13 5:36 PM View: | Alimera Sciences Inc (ALIM) | 15-May-13 | Market Sale | 251 | $4.70 | $1,179.70 | (< 1%) 40.79K to 40.54K | 94% |
| 22-Mar-13 6:19 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 21-Mar-13 | Market Sale (Planned) | 1,743 | $5.49 | $9,569.07 | (2%) 80.11K to 78.37K | (44%) |
| 21-Mar-13 5:13 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 20-Mar-13 | Market Sale (Planned) | 182 | $5.22 | $950.04 | (< 1%) 80.29K to 80.11K | (51%) |
| 21-Mar-13 5:13 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-13 | Market Sale (Planned) | 261 | $5.19 | $1,354.59 | (< 1%) 80.56K to 80.29K | (52%) |
| 19-Mar-13 4:47 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 18-Mar-13 | Market Sale (Planned) | 265 | $5.16 | $1,367.40 | (< 1%) 80.82K to 80.56K | (53%) |
| 19-Mar-13 4:47 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 15-Mar-13 | Market Sale (Planned) | 318 | $5.28 | $1,679.04 | (< 1%) 81.14K to 80.82K | (49%) |
| 15-Mar-13 5:02 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 14-Mar-13 | Market Sale (Planned) | 166 | $5.36 | $889.76 | (< 1%) 81.3K to 81.14K | (47%) |
| 15-Mar-13 5:02 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 13-Mar-13 | Market Sale (Planned) | 256 | $5.40 | $1,382.40 | (< 1%) 81.56K to 81.3K | (46%) |
| 13-Mar-13 8:40 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Mar-13 | Market Sale (Planned) | 210 | $5.38 | $1,129.80 | (< 1%) 81.77K to 81.56K | (46%) |
| 13-Mar-13 8:40 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 11-Mar-13 | Market Sale (Planned) | 136 | $5.34 | $726.24 | (< 1%) 81.91K to 81.77K | (48%) |
| 11-Mar-13 6:39 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 08-Mar-13 | Market Sale (Planned) | 171 | $5.32 | $909.72 | (< 1%) 82.08K to 81.91K | (48%) |
| 11-Mar-13 6:39 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 07-Mar-13 | Market Sale (Planned) | 420 | $5.22 | $2,192.40 | (< 1%) 82.5K to 82.08K | (51%) |
| 07-Mar-13 6:15 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 06-Mar-13 | Market Sale (Planned) | 127 | $5.06 | $642.62 | (< 1%) 82.62K to 82.5K | (56%) |
| 07-Mar-13 6:15 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 05-Mar-13 | Market Sale (Planned) | 134 | $5.01 | $671.34 | (< 1%) 82.76K to 82.62K | (57%) |
| 05-Mar-13 5:12 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 04-Mar-13 | Market Sale (Planned) | 170 | $5.01 | $851.70 | (< 1%) 82.93K to 82.76K | (57%) |
| 05-Mar-13 5:12 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 01-Mar-13 | Market Sale (Planned) | 253 | $5.01 | $1,267.53 | (< 1%) 83.18K to 82.93K | (57%) |
| 22-Feb-13 4:50 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 20-Feb-13 | Market Sale (Planned) | 66 | $5.01 | $330.66 | (< 1%) 83.25K to 83.18K | (57%) |
| 20-Feb-13 4:47 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Feb-13 | Market Sale (Planned) | 334 | $5.02 | $1,676.68 | (< 1%) 83.58K to 83.25K | (57%) |
| 20-Feb-13 4:47 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 15-Feb-13 | Market Sale (Planned) | 99 | $5.00 | $495.00 | (< 1%) 83.68K to 83.58K | (58%) |
| 15-Feb-13 5:08 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 14-Feb-13 | Market Sale (Planned) | 98 | $5.01 | $490.98 | (< 1%) 83.78K to 83.68K | (57%) |
| 15-Feb-13 5:08 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 13-Feb-13 | Market Sale (Planned) | 191 | $5.00 | $955.00 | (< 1%) 83.97K to 83.78K | (58%) |
| 05-Feb-13 6:14 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 01-Feb-13 | Market Sale (Planned) | 322 | $4.85 | $1,561.70 | (< 1%) 84.29K to 83.97K | (62%) |
| 01-Feb-13 5:22 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 31-Jan-13 | Market Sale (Planned) | 613 | $4.71 | $2,887.23 | (< 1%) 84.9K to 84.29K | (67%) |
| 01-Feb-13 5:22 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 30-Jan-13 | Market Sale (Planned) | 367 | $5.00 | $1,835.00 | (< 1%) 85.27K to 84.9K | (58%) |
| 30-Jan-13 7:14 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 29-Jan-13 | Market Sale (Planned) | 507 | $5.27 | $2,671.89 | (< 1%) 85.78K to 85.27K | (50%) |
| 30-Jan-13 7:14 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 28-Jan-13 | Market Sale (Planned) | 551 | $5.40 | $2,975.40 | (< 1%) 86.33K to 85.78K | (46%) |
| 28-Jan-13 7:45 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 25-Jan-13 | Market Sale (Planned) | 456 | $5.38 | $2,453.28 | (< 1%) 86.78K to 86.33K | (46%) |
| 28-Jan-13 7:45 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 24-Jan-13 | Market Sale (Planned) | 1,201 | $5.45 | $6,545.45 | (1%) 87.99K to 86.78K | (45%) |
| 24-Jan-13 4:41 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 23-Jan-13 | Market Sale (Planned) | 839 | $5.11 | $4,287.29 | (< 1%) 88.83K to 87.99K | (54%) |